PennyMac Mortgage Investment Trust Q4 FY2024 earnings call

• David noted strong Q4 results with 10% ROE, return to organic creation of credit investments, and repositioning balance sheet in 2024 including opportunistic sales, Agency MBS rebalance, $1.3B term debt issuance, and renewed mortgage banking agreement with PFSI.
• Dan discussed Q4 financial performance, run-rate return potential (currently $0.37 per share, with potential improvement if yield curve steepens), and capital position (retired CRT term notes, repaid exchangeable senior notes, plans to raise debt in 2025).
• Emphasis on organic CRT investments with favorable outlook (low LTV, low delinquency), stable MSR portfolio, and plans for continued securitization activity in 2025 including investor loans, jumbo loans, and potential non-QM if returns align.

In the fourth quarter, PMT earned $36 million in net income to common shareholders ($0.41 per diluted common share). Credit-sensitive strategies contributed $20 million in pre-tax income, with organically created CRT investments contributing $20 million, but offset by losses on non-agency subordinate MBS. Interest rate-sensitive strategies contributed pre-tax income of $25 million, with fair value increases on MSR investments ($184 million) offset by MBS fair value decrease ($140 million) and interest rate hedge changes ($51 million). For the full year, PMT had a return on common equity of 8% with $119 million of net income attributable to common shareholders. Approximately two-thirds of shareholders’ equity is in MSRs and GSE lender risk share transactions. MSR investments account for about half of deployed equity, with stable cash flows and low delinquencies. Correspondent loan acquisition volume in Q4 was $28 billion (up 9% from prior quarter), with PMT retaining 19% of conventional correspondent production in Q4, expecting 15%-25% in Q1 2025.

• Current run-rate return potential is $0.37 per share, unchanged from prior quarter. Slightly increased credit-sensitive strategies potential due to higher short-term rates, and improvement in interest-sensitive segment with steepened yield curve. Potential to reach $0.40 range if yield curve steepens further.
• Plans to raise additional debt in 2025 to address 2026 maturity of exchangeable note and fund securitization expansion.

• Interest rate volatility could impact fair value of interest rate-sensitive investments.
• Volatility in origination market and private label securitization conditions could affect securitization opportunities and spreads.
• Dependence on successful execution of securitization activities and ability to maintain favorable spreads for correspondent production.

Q: Bose George asks about yield curve steepening impact and MSR hedge strategy at PMT.

A: David Spector responds that yield curve steepness improves interest rate-sensitive strategies outlook, and PMT runs a tighter MSR hedge due to different MSR portfolio composition (more lower note rate loans) and less origination up-tick benefit compared to PFSI.

Q: Matthew Erdner inquires about GSE reform and new FHFA Director impact.

A: David Spector states it's early to judge new Director's actions, but PMT is prepared for various GSE environment outcomes, excited about investor loan securitization growth, and plans jumbo loan securitizations in 2025.

Q: Trevor Cranston asks about securitization product set beyond investor loans.

A: David Spector mentions ongoing investor loan securitization pace, plans for jumbo loan securitization in first half 2025, and consideration of non-QM but with work needed before action.

Q: Unidentified Analyst asks about liquidity and debt maturity.

A: Dan Perotti replies liquidity was $430M at quarter end, with plans to raise debt in 2025 to address 2026 exchangeable note maturity.

Q: Doug Harter asks about profitability of non-agency securitization vs conventional correspondent business.

A: Dan Perotti explains improvement in correspondent channel due to tighter market spreads in Q4, but run-rate reflects sustainable contribution, and David Spector adds investor loans have multiple delivery avenues (securitization, holding, GSE).